コーパス検索結果 (left1)
通し番号をクリックするとPubMedの該当ページを表示します
1 Responses were confirmed 4 weeks after the initial response.
2 Responses were confirmed by all investigators and an independ
3 All responses were confirmed 4 weeks later.
4 Biosensing responses were confirmed by immunohistochemistry, conducted o
5 Neoantigen-specific T
cell responses were confirmed in 19 of 22 (86.4%) evaluable patien
6 Tumor antigen-specific T-
cell responses were confirmed in six (38%) of 16 patients with ESC
7 For 6 epitopes, CD8+ T-
cell responses were confirmed in T cells derived from several mump
8 aused an increase in the IAS tone; these tissue
contractile responses were confirmed by single-cell contraction using mag
9 All primary
immune responses were confirmed by immunoblotting and immunoprecipit
10 Metabolic responses were confirmed in cultured muscle cells or cardiomy
11 If one or more
objective responses were confirmed, the trial would be expanded.
12 Odor responses were confirmed to result from retronasal olfaction:
13 Of 39 patients with BRAF wild-type melanoma, four
partial responses were confirmed (confirmed response rate, 10%).
14 Nine
partial responses were confirmed in patients with pancreatic cancer (
15 Six
partial responses were confirmed, including three at the MTD.
16 Pathologic responses were confirmed by central review.
17 Q3 responses were confirmed in all patients with an available el
18 Sensor responses were confirmed using a secondary antibody binding s
19 Taste responses were confirmed by delivery of four basic tastants t